BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 16614873)

  • 1. Completion lymphadenectomy for melanoma patients with a positive sentinel node biopsy remains standard of care.
    Henderson MA
    Ann Surg Oncol; 2006 Jun; 13(6):761-3. PubMed ID: 16614873
    [No Abstract]   [Full Text] [Related]  

  • 2. Sentinel lymph node biopsy and completion lymph node dissection for malignant melanoma are not standard of care.
    Coldiron BM; Dinehart S; Rogers HW
    Clin Dermatol; 2009; 27(4):350-4. PubMed ID: 19539161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy for melanoma--standard of care?
    Otley CC
    Dermatol Surg; 2000 Nov; 26(11):1067-9. PubMed ID: 11096398
    [No Abstract]   [Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.
    Molenkamp BG; Statius Muller MG; Vuylsteke RJ; van der Sijp JR; Meijier S; van Leeuwen PA
    Eur J Surg Oncol; 2005 Mar; 31(2):211-2. PubMed ID: 15698742
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathobiology of the sentinel node.
    Cochran AJ; Ohsie SJ; Binder SW
    Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma patients with melanoma micrometastases in sentinel node that refused completion lymphadenectomy.
    Manganoni AM; Farisoglio C; Tucci G; Facchetti F; Farfaglia R; Pizzocaro C; Ungari M; Calzavara-Pinton PG
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1008-9. PubMed ID: 18201174
    [No Abstract]   [Full Text] [Related]  

  • 8. Sentinel lymphadenectomy for cutaneous melanoma: who, what, and why.
    Bower M; Scoggins CR
    J Ky Med Assoc; 2009 Jul; 107(7):253-8. PubMed ID: 19678500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.
    Caracò C; Marone U; Celentano E; Botti G; Mozzillo N
    Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in sentinel lymph node-positive melanoma.
    Miranda EP
    J Clin Oncol; 2006 Nov; 24(32):5178; author reply 5178. PubMed ID: 17093288
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark.
    Pawlik TM; Ross MI; Shaw HM; Thompson JF; Gershenwald JE
    Eur J Surg Oncol; 2005 Apr; 31(3):323-4. PubMed ID: 15780572
    [No Abstract]   [Full Text] [Related]  

  • 13. Regarding sentinel node biopsy in the management of melanoma.
    Coldiron B
    Dermatol Surg; 2001 Jan; 27(1):95-7. PubMed ID: 11231262
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolated tumor cells and long-term prognosis of patients with melanoma.
    van Akkooi AC; de Wilt JH; Verhoef C; Eggermont AM
    Ann Surg Oncol; 2008 May; 15(5):1547-8. PubMed ID: 18197454
    [No Abstract]   [Full Text] [Related]  

  • 15. The persistent anchor of lymph node removal in patients with melanoma.
    Byrd DR
    Cancer; 2010 Mar; 116(5):1150-2. PubMed ID: 20066718
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymph node ratio in melanoma: A marker of variation in surgical quality?
    Spillane AJ; Winstanley J; Thompson JF
    Cancer; 2009 Jun; 115(11):2384-7. PubMed ID: 19306419
    [No Abstract]   [Full Text] [Related]  

  • 17. The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB).
    Russell-Jones R; Powell AM; Acland K; Calonje E; O'Doherty M; Healy C
    Eur J Surg Oncol; 2005 Mar; 31(2):210-1. PubMed ID: 15698741
    [No Abstract]   [Full Text] [Related]  

  • 18. Sentinel node mapping for melanoma: results of trials and current applications.
    Thompson JF; Shaw HM
    Surg Oncol Clin N Am; 2007 Jan; 16(1):35-54. PubMed ID: 17336235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
    Aloia TA; Gershenwald JE; Andtbacka RH; Johnson MM; Schacherer CW; Ng CS; Cormier JN; Lee JE; Ross MI; Mansfield PF
    J Clin Oncol; 2006 Jun; 24(18):2858-65. PubMed ID: 16782925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.